Centogene NV (STU:39K) Inventories, Finished Goods : €0.20 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Inventories, Finished Goods?

Centogene NV's quarterly finished goods declined from Dec. 2022 (€0.02 Mil) to Jun. 2023 (€0.00 Mil) but then increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.20 Mil).

Centogene NV's annual finished goods declined from Dec. 2021 (€0.04 Mil) to Dec. 2022 (€0.02 Mil) but then increased from Dec. 2022 (€0.02 Mil) to Dec. 2023 (€0.20 Mil).

Centogene NV Inventories, Finished Goods Historical Data

The historical data trend for Centogene NV's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Inventories, Finished Goods Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.17

0.24

0.04

0.02

0.20

Centogene NV Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23	Dec23
Inventories, Finished Goods	Get a 7-Day Free Trial															-	-	0.02	-	0.20

Centogene NV Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Centogene NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (STU:39K) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

CNTGF:USA

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.

Centogene NV Headlines

No Headlines